Literature DB >> 34257494

Percutaneous Deep Vein Arterialization for a Chronic Limb-Threatening Ischemia Patient in Taiwan.

Hui-Wen Chang1, Chung-Ho Hsu2, You-Cheng Jhang2, Chun-Cheng Wang2, Chiz-Tzung Chang3, Hung-Chih Chen4,5.   

Abstract

Entities:  

Year:  2021        PMID： 34257494      PMCID： PMC8261698          DOI： 10.6515/ACS.202107_37(4).20210310A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  9 in total

1.  Distal venous arterialization for lower limb salvage: angiographic appearances and interventional procedures.

Authors:  C Engelke; R A Morgan; J W Quarmby; R S Taylor; A M Belli
Journal:  Radiographics       Date:  2001 Sep-Oct       Impact factor: 5.333

Review 2.  Medical treatment of peripheral arterial disease and claudication.

Authors:  W R Hiatt
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

3.  [Arteriovenous anastomosis in the treatment of gangrene of the extremities caused by arterial obliteration].

Authors:  G POZZI
Journal:  Ann Ital Chir       Date:  1954       Impact factor: 0.766

4.  Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.

Authors:  Michael S Conte; Andrew W Bradbury; Philippe Kolh; John V White; Florian Dick; Robert Fitridge; Joseph L Mills; Jean-Baptiste Ricco; Kalkunte R Suresh; M Hassan Murad; Victor Aboyans; Murat Aksoy; Vlad-Adrian Alexandrescu; David Armstrong; Nobuyoshi Azuma; Jill Belch; Michel Bergoeing; Martin Bjorck; Nabil Chakfé; Stephen Cheng; Joseph Dawson; Eike S Debus; Andrew Dueck; Susan Duval; Hans H Eckstein; Roberto Ferraresi; Raghvinder Gambhir; Mauro Gargiulo; Patrick Geraghty; Steve Goode; Bruce Gray; Wei Guo; Prem C Gupta; Robert Hinchliffe; Prasad Jetty; Kimihiro Komori; Lawrence Lavery; Wei Liang; Robert Lookstein; Matthew Menard; Sanjay Misra; Tetsuro Miyata; Greg Moneta; Jose A Munoa Prado; Alberto Munoz; Juan E Paolini; Manesh Patel; Frank Pomposelli; Richard Powell; Peter Robless; Lee Rogers; Andres Schanzer; Peter Schneider; Spence Taylor; Melina V De Ceniga; Martin Veller; Frank Vermassen; Jinsong Wang; Shenming Wang
Journal:  Eur J Vasc Endovasc Surg       Date:  2019-06-08       Impact factor: 7.069

5.  Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia.

Authors:  Steven Kum; Yih Kai Tan; Michiel A Schreve; Roberto Ferraresi; Ramon L Varcoe; Andrej Schmidt; Dierk Scheinert; Jihad A Mustapha; Darryl M Lim; Derek Ho; Tjun Y Tang; Vlad-Adrian Alexandrescu; Pramook Mutirangura
Journal:  J Endovasc Ther       Date:  2017-07-12       Impact factor: 3.487

6.  Deep calf veins arterialization for inferior limb preservation in diabetic patients with extended ischaemic wounds, unfit for direct arterial reconstruction: preliminary results according to an angiosome model of perfusion.

Authors:  Vlad Alexandrescu; Christian Ngongang; Gaetane Vincent; Gilles Ledent; Gérard Hubermont
Journal:  Cardiovasc Revasc Med       Date:  2010-10-20

Review 7.  Venous Arterialisation for Salvage of Critically Ischaemic Limbs: A Systematic Review and Meta-Analysis.

Authors:  M A Schreve; C G Vos; A C Vahl; J P P M de Vries; S Kum; G J de Borst; Ç Ünlü
Journal:  Eur J Vasc Endovasc Surg       Date:  2016-12-24       Impact factor: 7.069

8.  Percutaneous Deep Venous Arterialization for Severe Critical Limb Ischemia in Patients With No Option of Revascularization: Early Experience From Two European Centers.

Authors:  C Del Giudice; D Van Den Heuvel; J Wille; T Mirault; E Messas; R Ferraresi; S Kum; M Sapoval
Journal:  Cardiovasc Intervent Radiol       Date:  2018-07-17       Impact factor: 2.740

9.  Hybrid Foot Vein Arterialization in No-Option Patients With Critical Limb Ischemia: A Preliminary Report.

Authors:  Roberto Ferraresi; Andrea Casini; Fabrizio Losurdo; Maurizio Caminiti; Alessandro Ucci; Matteo Longhi; Michiel Schreve; Michael Lichtenberg; Steven Kum; Giacomo Clerici
Journal:  J Endovasc Ther       Date:  2018-12-28       Impact factor: 3.487
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.